Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919353 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
Targeting Ras and PI3K activity improves the outcome of irradiation in cetuximab-resistant HNSCC cell lines in vitro.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mohammad Saki, Mahmoud Toulany, H. Peter Rodemann,